Skip to main content

This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH).

Essential cookies
These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable information.

Performance cookies
These cookies allow us to count visits and traffic sources so that we can measure and improve the performance of our website.

To Lund University

CREATE Health

Lund University

About
Funding Centre management Recruitment
Research and Innovation
Focus Areas Major Achievements Services Ongoing Collaborations and partners Spin Outs
CanFaster
Publications News Ongoing CanFaster PhD projects Ongoing CanFaster postdoc projects Finished CanFaster projects Contact
Contact

Start
CanFaster
Ongoing CanFaster postdoc projects

About
Research and Innovation
CanFaster
Contact

Publications
News
Ongoing CanFaster PhD projects
Ongoing CanFaster postdoc projects
Finished CanFaster projects
Contact

Ongoing CanFaster postdoc projects

Next generation immuno-oncological targets for cancer therapy
Tracking of mutations in circulating tumour DNA to monitor relapse in breast cancer
Inducing anti-tumor immunity with in-situ direct reprograming of cancer cells to cDC1s
Subtype-dependent biomarkers for systemic therapy in bladder cancer

Page Manager: jana.hagman@immun.lth.se | 2023-11-01

Contact us

CREATE Health
Lund University
Box 118
221 00 LUND
+46 46 222 00 00 (switchboard)

Accessibility statement